Whole genome sequence of multiple myeloma-prone C57BL/KaLwRij mouse strain suggests the origin of disease involves multiple cell types

PLoS ONE

Volumn 10, Issue 5, 2015, Pages

  Amend, Sarah R ^a   Wilson, William C ^a   Chu, Liang ^a   Lu, Lan ^a   Liu, Pengyuan ^b   Serie, Daniel ^d   Su, Xinming ^a   Xu, Yalin ^a   Wang, Dingyan ^c   Gramolini, Anthony ^c   Wen, Xiao Yan ^c   O'Neal, Julie ^a   Hurchla, Michelle ^a   Vachon, Celine M ^d   Colditz, Graham ^a   Vij, Ravi ^a   Weilbaecher, Katherine N ^a   Tomasson, Michael H ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

^c UNIVERSITY OF TORONTO   (Canada)

^d Mayo Clinic College of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; BONE MARROW CELL; CELL ASSAY; CELL FUNCTION; CELLS BY BODY ANATOMY; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE COURSE; DNA SEQUENCE; FEMALE; GENE; GENE DELETION; GENETIC VARIABILITY; MACROPHAGE; MOLECULAR PATHOLOGY; MOUSE; MULTIPLE MYELOMA; NONHUMAN; PHENOTYPE; POINT MUTATION; SAMSN1 GENE; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; TNFRSF22 GENE; TNFRSF23 GENE; WHOLE GENOME SEQUENCE; ANIMAL; GENETICS; GENOME-WIDE ASSOCIATION STUDY; HUMAN; METABOLISM; PATHOLOGY; STROMA CELL;

MUS;

SLY2 PROTEIN, MOUSE; TNFRH2 PROTEIN, MOUSE; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR PROTEIN; VESICULAR TRANSPORT ADAPTOR PROTEIN;

ADAPTOR PROTEINS, VESICULAR TRANSPORT; ANIMALS; B-LYMPHOCYTES; BONE MARROW CELLS; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MACROPHAGES; MICE; MULTIPLE MYELOMA; NEOPLASM PROTEINS; POINT MUTATION; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, TUMOR NECROSIS FACTOR; STROMAL CELLS;

EID: 84932602156     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0127828     Document Type: Article

References (21)

1. Kumar SK, Dispenzieri A, Lacy MQ, Gertz MA, Buadi FK, Pandey S, et al. Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients. Leukemia. 2013.
2. Landgren O, Gridley G, Turesson I, Caporaso NE, Goldin LR, Baris D, et al. Risk of monoclonal gammopathy of undetermined significance (MGUS) and subsequent multiple myeloma among African American and white veterans in the United States. Blood. 2006; 107(3):904-6. PMID: 16210333
3. Kyle RA, Durie BG, Rajkumar SV, Landgren O, Blade J, Merlini G, et al. Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management. Leukemia. 2010; 24(6):1121-7. doi: 10.1038/leu.2010.60 PMID: 20410922
4. Kyle RA, Therneau TM, Rajkumar SV, Larson DR, Plevak MF, Offord JR, et al. Prevalence of monoclonal gammopathy of undetermined significance. The New England journal of medicine. 2006; 354 (13):1362-9. PMID: 16571879
5. Weinhold N, Johnson DC, Rawstron AC, Forsti A, Doughty C, Vijayakrishnan J, et al. Inherited genetic susceptibility to monoclonal gammopathy of unknown significance. Blood. 2014; 123(16):2513-7. doi: 10.1182/blood-2013-10-532283 PMID: 24449210
6. Davies FE, Dring AM, Li C, Rawstron AC, Shammas MA, O'Connor SM, et al. Insights into the multistep transformation of MGUS to myeloma using microarray expression analysis. Blood. 2003; 102 (13):4504-11. PMID: 12947006
7. Epstein J, Yaccoby S. The SCID-hu myeloma model. (1543-1894 (Print)).
8. Radl J, Hollander CF, van den Berg P, de Glopper E. Idiopathic paraproteinaemia. I. Studies in an animal model-the ageing C57BL/KaLwRij mouse. Clinical and experimental immunology. 1978; 33 (3):395-402. PMID: 367647
9. Wang D, Stewart AK, Zhuang L, Zhu Y, Wang Y, Shi C, et al. Enhanced adaptive immunity in mice lacking the immunoinhibitory adaptor Hacs1. FASEB journal: official publication of the Federation of American Societies for Experimental Biology. 2010; 24(3):947-56.
10. Garrett IR, Dallas S, Radl J, Mundy GR. A murine model of human myeloma bone disease. Bone. 1997; 20(6):515-20. PMID: 9177864
11. Claudio JO, Zhu YX, Benn SJ, Shukla AH, McGlade CJ, Falcioni N, et al. HACS1 encodes a novel SH3-SAM adaptor protein differentially expressed in normal and malignant hematopoietic cells. Oncogene. 2001; 20(38):5373-7. PMID: 11536050
12. Fowler JA, Lwin ST, Drake MT, Edwards JR, Kyle RA, Mundy GR, et al. Host-derived adiponectin is tumor-suppressive and a novel therapeutic target for multiple myeloma and the associated bone disease. Blood. 2011; 118(22):5872-82. doi: 10.1182/blood-2011-01-330407 PMID: 21908434
13. Lohr JG, Stojanov P, Carter SL, Cruz-Gordillo P, Lawrence MS, Auclair D, et al. Widespread genetic heterogeneity in multiple myeloma: implications for targeted therapy. (1878-3686 (Electronic)).
14. Chapman MA, Lawrence MS, Keats JJ, Cibulskis K, Sougnez C, Schinzel AC, et al. Initial genome sequencing and analysis of multiple myeloma. Nature. 2011; 471(7339):467-72. doi: 10.1038/nature09837 PMID: 21430775
15. Sarah Amend LC, Daniel Serie, Celine M Vachon, Lan Lu, Ravi Vij, Graham A Colditz, Katherine N Weilbaecher, Michael H. Tomasson, editor Deletion of samsn1 underlies genetic susceptibility to MGUS in mice. 55th American Society of Hematology Annual Meeting and Exposition; Dec. 9th, 2013; New Orleans, LA: 55th American Society of Hematology Annual Meeting and Exposition.
16. Schneider P, Olson D Fau-Tardivel A, Tardivel A Fau-Browning B, Browning B Fau-Lugovskoy A, Lugovskoy A Fau-Gong D, Gong D Fau-Dobles M, et al. Identification of a new murine tumor necrosis factor receptor locus that contains two novel murine receptors for tumor necrosis factor-related apoptosis: inducing ligand (TRAIL). (0021-9258 (Print)).
17. Colucci S, Brunetti G, Rizzi R, Zonno A, Mori G, Colaianni G, et al. T cells support osteoclastogenesis in an in vitro model derived from human multiple myeloma bone disease: the role of the OPG/TRAIL interaction. Blood. 2004; 104(12):3722-30. PMID: 15308561
18. Zhu YX, Benn S, Li ZH, Wei E, Masih-Khan E, Trieu Y, et al. The SH3-SAM adaptor HACS1 is up-regulated in B cell activation signaling cascades. The Journal of experimental medicine. 2004; 200(6):737-47. PMID: 15381729
19. von Holleben M, Gohla A, Janssen KP, Iritani BM, Beer-Hammer S. Immunoinhibitory adapter protein Src homology domain 3 lymphocyte protein 2 (SLy2) regulates actin dynamics and B cell spreading. The Journal of biological chemistry. 2011; 286(15):13489-501. doi: 10.1074/jbc.M110.155184 PMID: 21296879
20. Chng WJ, Kumar S, Vanwier S, Ahmann G, Price-Troska T, Henderson K, et al. Molecular dissection of hyperdiploid multiple myeloma by gene expression profiling. Cancer research. 2007; 67(7):2982-9. PMID: 17409404
21. Edgar R, Domrachev M, Lash AE. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic acids research. 2002; 30(1):207-10. doi: D-NLM:PMC99122EDAT:2001/12/2610:00MHDA-2002/01/2210:01CRDT-2001/12/2610:00 PST-ppublish. PMID: 11752295